ASR Vermogensbeheer N.V. Invests $7.74 Million in Exelon Corporation (NASDAQ:EXC)

Key Points

• ASR Vermogensbeheer N.V. acquired a new stake in Exelon Corporation, purchasing 167,859 shares valued at approximately $7.74 million.
• Exelon reported a Q2 earnings of $0.39 EPS, exceeding the consensus estimate of $0.37, and had quarterly revenues of $5.43 billion.
• The company has recently announced a quarterly dividend of $0.40 per share, with a dividend yield of 3.6% based on a payout ratio of 60.84%.

ASR Vermogensbeheer N.V. acquired a new stake in Exelon Corporation (NASDAQ:EXC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 167,859 shares of the company's stock, valued at approximately $7,735,000.

Several other large investors also recently made changes to their positions in the stock. Ameriflex Group Inc. acquired a new stake in shares of Exelon in the fourth quarter valued at approximately $25,000. Hazlett Burt & Watson Inc. grew its position in shares of Exelon by 46.4% in the first quarter. Hazlett Burt & Watson Inc. now owns 694 shares of the company's stock valued at $32,000 after purchasing an additional 220 shares during the last quarter. ANTIPODES PARTNERS Ltd acquired a new position in shares of Exelon in the first quarter valued at approximately $34,000. MJT & Associates Financial Advisory Group Inc. acquired a new position in shares of Exelon in the first quarter valued at approximately $42,000. Finally, Opal Wealth Advisors LLC acquired a new position in shares of Exelon in the first quarter valued at approximately $50,000. Institutional investors and hedge funds own 80.92% of the company's stock.

Exelon Price Performance

Shares of NASDAQ EXC traded down $0.22 during trading hours on Friday, hitting $45.32. 3,803,099 shares of the stock were exchanged, compared to its average volume of 6,082,460. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.85 and a current ratio of 0.95. The company has a market cap of $45.77 billion, a PE ratio of 17.23, a price-to-earnings-growth ratio of 2.66 and a beta of 0.38. The company's fifty day simple moving average is $43.44 and its two-hundred day simple moving average is $43.80. Exelon Corporation has a 1-year low of $35.94 and a 1-year high of $48.11.

Exelon (NASDAQ:EXC - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.02. The business had revenue of $5.43 billion during the quarter, compared to analysts' expectations of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. The firm's quarterly revenue was up 1.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.47 EPS. On average, sell-side analysts predict that Exelon Corporation will post 2.64 EPS for the current year.

Exelon Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Monday, August 11th will be given a dividend of $0.40 per share. The ex-dividend date is Monday, August 11th. This represents a $1.60 annualized dividend and a yield of 3.5%. Exelon's dividend payout ratio (DPR) is currently 60.84%.

Analyst Ratings Changes

EXC has been the topic of several research reports. KeyCorp decreased their target price on Exelon from $39.00 to $37.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 16th. Morgan Stanley decreased their target price on Exelon from $49.00 to $48.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 22nd. Wells Fargo & Company lifted their price target on shares of Exelon from $46.00 to $50.00 and gave the company an "equal weight" rating in a research report on Friday, May 2nd. Guggenheim lifted their price target on shares of Exelon from $47.00 to $50.00 and gave the company a "buy" rating in a research report on Friday, May 2nd. Finally, UBS Group reiterated a "neutral" rating and issued a $48.00 price target (up from $47.00) on shares of Exelon in a research report on Friday, July 11th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, Exelon presently has a consensus rating of "Hold" and a consensus target price of $47.20.

Exelon Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.